SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-15-360263
Filing Date
2015-10-30
Accepted
2015-10-30 16:06:11
Documents
4
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q d83249d10qa.htm 10-Q/A 28001
2 EX-10.1 d83249dex101.htm EX-10.1 171364
3 EX-31.1 d83249dex311.htm EX-31.1 3208
4 EX-31.2 d83249dex312.htm EX-31.2 3175
  Complete submission text file 0001193125-15-360263.txt   206721
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36544 | Film No.: 151187516
SIC: 2834 Pharmaceutical Preparations